Join
Live feed
·
PRReleasevia Quantisnow
Bolt Biotherapeutics Inc. logo

Bolt Biotherapeutics Reports First Quarter 2024 Results, Announces Strategic Pipeline Prioritization and Changes to Leadership Team

ByQuantisnow·Wall Street's wire, on your screen.
BOLT· Bolt Biotherapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BOLT (Bolt Biotherapeutics Inc.) and more on Quantisnow.